Search Results - "Monreal Bosch, M"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2
  3. 3

    Controversias sobre la enfermedad tromboembólica venosa no provocada en ancianos by Monreal Bosch, Manuel, Ríos Prego, M, Núñez Fernández, Manuel Jesús

    Published in Galicia-clinica (2016)
    “…La forma no provocada de enfermedad tromboembólica venosa (ETV) representa aproximadamente la mitad de los casos de esta patología en ancianos. Como lo…”
    Get full text
    Journal Article
  4. 4

    Update on the risk stratification of acute symptomatic pulmonary thromboembolism by Maestre Peiró, A., Gonzálvez Gasch, A., Monreal Bosch, M.

    “…Early mortality in patients with pulmonary thromboembolism (PTE) varies from 2% in normotensive patients to 30% in patients with cardiogenic shock. The current…”
    Get full text
    Journal Article
  5. 5

    Comparison of the cost-utility of direct oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in Spain by Monreal-Bosch, M, Soulard, S, Crespo, C, Brand, S, Kansal, A

    Published in Revista de neurologiá (16-03-2017)
    “…Apixaban, dabigatran and rivaroxaban are three new direct oral anticoagulants (DOACs) used in the prevention of stroke and systemic embolism in patients with…”
    Get full text
    Journal Article
  6. 6

    Current indications of heparin treatment by Monreal Bosch, M

    Published in Revista clínica espanõla (01-02-2006)
    “…The last guidelines on treatment of venous thromboembolic disease recommend the use of unfractionated heparin (UFH) or low molecular weight heparin (LMWH). In…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Computerized registry of patients with thromboembolic disease in Spain (RIETE): background, objectives, methods, and preliminary results by Suárez Fernández, C, González-Fajardo, J A, Monreal Bosch, M

    Published in Revista clínica espanõla (01-02-2003)
    “…Venous thromboembolic disease (VTD) is a common and severe condition. Its anticoagulation-based treatment is not without complications and failures. To create…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13